Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Elvucitabine

Generic Name: Elvucitabine

Drug Type: Small Molecule

Chemical Formula: C_₉H_₁₀FN_₃O_₃

CAS Number: 181785-84-2

Unique Ingredient Identifier: M09BUF90C0

Overview

No overview information available.

Background

No background information available.

Indication

Investigated for use/treatment in hepatitis (viral, B) and HIV infection.

Associated Conditions

No associated conditions information available.

Clinical Trials

An Open-Label Treatment Protocol to Provide Continued Elvucitabine Treatment

Phase 2

Completed

Posted: 2008/05/12

Sponsor:Alexion Pharmaceutic...

ID:NCT00675844

Safety Study of Elvucitabine in HIV-1 Subjects

Phase 2

Completed

Posted: 2006/11/30

Sponsor:Thomas Jefferson Uni...

ID:NCT00405249

Open-Label, 48-Week Extension Study of Elvucitabine in Combination With Background Antiretroviral Therapy (ART) for Participants Who Have Completed Study ACH443-014A

Phase 2

Completed

Posted: 2006/09/25

Sponsor:Alexion Pharmaceutic...

ID:NCT00380159

Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-naive Participants

Phase 2

Completed

Posted: 2006/07/10

Sponsor:Alexion Pharmaceutic...

ID:NCT00350272

Study of Once Daily Elvucitabine Versus Lamivudine in Participants With a Documented M184V Mutation

Phase 1

Completed

Posted: 2006/04/07

Sponsor:Alexion Pharmaceutic...

ID:NCT00312039

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy